News
(UPDATED) Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, ...
Please provide your email address to receive an email when new articles are posted on . Taking low-dose aspirin every day was linked to a 23.5% risk for developing anemia within 5 years among older ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." You may have heard that taking a low dose of aspirin every day can boost your heart health. Last year, ...
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
It's already being taken by millions to help ward off heart issues, and now preliminary research hints that daily low-dose aspirin might also cut your odds of contracting COVID-19. As the Israeli ...
Share on Pinterest Low dose aspirin is recommended for some people who have had major cardiac events. Valentina Barreto/Stocksy United A study looked at whether taking low dose aspirin reduces the ...
April 28, 2010 — The risk for low-dose aspirin (LDA)–associated peptic ulcer is higher in elderly women, according to the results of a study reported in the April 21 issue of World Journal of ...
June 19 (UPI) --Using low-dose aspirin was associated with a 20% increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults, according to a new ...
Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just as ...
Please provide your email address to receive an email when new articles are posted on . Incidence of AMD was 19.4% in the aspirin group and 19.1% in the placebo group. Progression from ...
Over a median of 4.7 years, the incidence of anemia was 51.2 events per 1,000 person-years in the aspirin group compared with 42.9 events per 1,000 person-years in the placebo group (HR 1.20, 95% CI 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results